Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 2 |
Cisco
CSCO
|
+$327M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$305M |
| 4 |
Archer Daniels Midland
ADM
|
+$174M |
| 5 |
Johnson & Johnson
JNJ
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$688M |
| 2 |
Royal Bank of Canada
RY
|
+$526M |
| 3 |
Toronto Dominion Bank
TD
|
+$457M |
| 4 |
Scotiabank
BNS
|
+$414M |
| 5 |
Canadian National Railway
CNI
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.54% |
| 2 | Energy | 14.01% |
| 3 | Miscellaneous | 12.57% |
| 4 | Industrials | 8.26% |
| 5 | Technology | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2501
Amkor Technology
AMKR
$13.9B
| $213K | ﹤0.01% |
25,365
-3,922
| -13% | -$38.8K |
2014 Q1
2 quarters
|
|
2502
Lloyds Banking Group
LYG
$79.1B
| $213K | ﹤0.01% |
42,223
-278
| -0.7% | -$1.4K |
2013 Q2
5 quarters
|
|
2503
Zumiez
ZUMZ
$204M
| $213K | ﹤0.01% |
7,579
+2,158
| +40% | +$63.4K |
2013 Q2
5 quarters
|
|
|
CSS
2504
DELISTED
CSS Industries, Inc.
CSS
| $213K | ﹤0.01% |
8,784
-349
| -4% | -$8.88K |
2013 Q2
5 quarters
|
|
|
NILE
2505
DELISTED
Blue Nile, Inc.
NILE
| $213K | ﹤0.01% |
7,442
-131
| -2% | -$3.65K |
2013 Q2
5 quarters
|
|
|
DYAX
2506
DELISTED
DYAX CORPORATION
DYAX
| $213K | ﹤0.01% |
21,074
+17,664
| +518% | +$171K |
2014 Q2
1 quarter
|
|
|
OREX
2507
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $213K | ﹤0.01% |
5,000
+3,850
| +335% | +$207K |
2014 Q2
1 quarter
|
|
2508
Sprott Physical Silver Trust
PSLV
$12.4B
| $212K | ﹤0.01% |
30,820
-1,150
| -4% | -$9.13K |
2013 Q2
5 quarters
|
|
2509
WSFS Financial
WSFS
$3.99B
| $212K | ﹤0.01% |
8,913
-675
| -7% | -$16.3K |
2013 Q2
5 quarters
|
|
2510
Idacorp
IDA
$7.68B
| $211K | ﹤0.01% |
3,953
+1,028
| +35% | +$56.6K |
2013 Q2
5 quarters
|
|
2511
MannKind Corp
MNKD
$1.22B
| $211K | ﹤0.01% |
7,130
-848
| -11% | -$33.5K |
2013 Q2
5 quarters
|
|
|
TPLM
2512
DELISTED
Triangle Petroleum Corporation
TPLM
| $211K | ﹤0.01% |
19,131
+1,555
| +9% | +$17.7K |
2013 Q4
3 quarters
|
|
2513
Credit Acceptance
CACC
$5.48B
| $210K | ﹤0.01% |
1,664
-91
| -5% | -$11.2K |
2013 Q2
5 quarters
|
|
2514
Wolfspeed
WOLF
$1.87B
| $210K | ﹤0.01% |
5,102
-1,640
| -24% | -$75.7K |
2013 Q2
5 quarters
|
|
|
VIRX
2515
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $210K | ﹤0.01% |
140
-267
| -66% | -$387K |
2014 Q1
2 quarters
|
|
|
XLS
2516
DELISTED
EXELIS INC COM STK
XLS
| $210K | ﹤0.01% |
12,665
-4,107
| -24% | -$66.7K |
2013 Q2
5 quarters
|
|
2517
Walker & Dunlop
WD
$1.17B
| $209K | ﹤0.01% |
15,739
+370
| +2% | +$5.13K |
2014 Q1
2 quarters
|
|
2518
Lattice Semiconductor
LSCC
$19B
| $208K | ﹤0.01% |
27,621
-3,340
| -11% | -$25.1K |
2013 Q2
5 quarters
|
|
2519
Tootsie Roll Industries
TR
$2.86B
| $208K | ﹤0.01% |
10,603
-776
| -7% | -$15.2K |
2013 Q2
5 quarters
|
|
2520
Liberty All-Star Equity Fund
USA
$1.79B
| $208K | ﹤0.01% |
35,599
+26
| +0.1% | +$154 |
2013 Q2
5 quarters
|
|
|
BLT
2521
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $208K | ﹤0.01% |
13,724
+12,514
| +1,034% | +$186K |
2014 Q2
1 quarter
|
|
|
OMED
2522
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $208K | ﹤0.01% |
11,000
-2,120
| -16% | -$42.6K |
2013 Q4
3 quarters
|
|
2523
National Health Investors
NHI
$3.23B
| $206K | ﹤0.01% |
3,610
-564
| -14% | -$35K |
2013 Q2
5 quarters
|
|
|
GWPH
2524
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $206K | ﹤0.01% |
2,550
-100
| -4% | -$8.85K |
2013 Q2
5 quarters
|
|
|
EOX
2525
DELISTED
EMERALD OIL INC (MT)
EOX
| $206K | ﹤0.01% |
1,677
+914
| +120% | +$139K |
2013 Q2
5 quarters
|
|
Similar funds
Bank of Montreal's Q3 2014 Portfolio in Review
As of Q3 2014, Bank of Montreal held 5,003 positions worth $88.3B, down 1.4% from $89.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of Montreal's Q3 2014 filing shows 320 new, 1,431 increased, 1,887 reduced and 935 closed positions. Its largest new stake was Cisco: 13,004,651 shares worth $327M. The largest sale was Apple, an estimated $688M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Energy and Miscellaneous.
- Bank of Montreal's largest Q3 2014 buy was Cisco: 13,004,651 shares worth $327M.
- Bank of Montreal added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $381M increase.
- Bank of Montreal's biggest Q3 2014 reduction was Apple, cutting an estimated $688M.
- Bank of Montreal fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $15M.
- Bank of Montreal's ten largest holdings make up 23% of its $88.3B portfolio in Q3 2014.
- Bank of Montreal opened 320 new positions and closed 935 in Q3 2014.
- Bank of Montreal's portfolio value fell 1.4% quarter-over-quarter to $88.3B.
Based on Bank of Montreal's 13F filing for Q3 2014, filed 7 Nov 2014.